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1.1. Roles of lipid headgroups and acyl chains in the interactions of
proteins with membranes
The interaction of proteins with membranes will often involve
both non-speciﬁc interactions as well as binding to speciﬁc groups.
Examples of non-speciﬁc interactions can include electrostatic,
hydrophobic, van der Waals and H-bonding interactions. In contrast,
speciﬁc interactions depend on a combination of several of these
types of non-covalent interactions localized within a folded domain,
resulting in a higher afﬁnity binding. Examples have been given
indicating that the binding of the coagulation factor X [1] or the
binding of annexin V with Ca2+ [2] is dependent only on non-speciﬁc
electrostatic interactions with the membrane. In contrast, other
proteins have folded domains that bind to speciﬁc lipid molecules in
a membrane. There are many examples of speciﬁc interactions with
lipids among proteins involved in signal transduction [3].
The role of lipid acyl chains in binding to proteins, is generally non-
speciﬁc. Unlike the headgroup, the acyl chains have a limited degree
of speciﬁc structural features and this region of the membrane has a
high degree of disorder in ordinary liquid crystalline bilayers.
Furthermore, the principal types of non-covalent binding forces thatcan occur with these hydrocarbon chains are limited, involving
principally hydrophobic and van derWaals interactions. In addition to
direct binding interactions with the protein, the acyl chains can also
contribute to determining the degree of non-speciﬁc interactions
through their role in determining the membrane lateral pressure
proﬁle that will contribute to the partitioning of molecules into the
membrane [4]. The acyl chains will contribute to determining the
thickness of the bilayer that has to match the thickness of protein
segments that traverse the membrane as predicted by the mattress
model [5]. Nevertheless there are examples indicating speciﬁcity of
binding to particular acyl chains. For example, covalent modiﬁcation
of proteins by acylation on an amino terminal Gly occurs always with
the myristic acid moiety and not any other acyl chain, while covalent
modiﬁcation by acylation of the sulphydryl group of proteins is with
palmitoyl moieties. The transfer of an acyl chain to LPS in E. coli by
PagP is also speciﬁc for a chain length of 16 carbon atoms [6]. The
present review will focus on the recognition of polyunsaturated acyl
chains (PUFA) in the interaction of proteins and lipids.
1.2. Importance of polyunsaturated acyl chains (PUFA) in human
nutrition
PUFA are essential components in the human diet as they cannot
be synthesized de novo from saturated or monounsaturated fatty
acids. These lipids have important roles in human health [7,8].
Docosahexanoic acyl chains (22:6) are particularly abundant in the
brain where they appear to have an important role in brain function
and development [9]. Arachidonoyl chains (20:4) also have an
important role in providing free arachidonic acid that is a precursor
for many potent prostanoid ligands [10]. The rate of production of
these active signaling metabolites of arachidonic acid is determined
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phospholipid hydrolysis catalyzed by phospholipase A2.
1.3. Non-uniform distribution of PUFA in different lipid classes
All fatty acids have membrane-disrupting, detergent-like proper-
ties in their anionic form at neutral pH. Hence, free PUFAs are found in
biological specimens only at very low concentrations. Most PUFAs are
found as acyl chain components that are covalently attached to
phospholipids. There is selective distribution of PUFAs among
different lipid classes and among different organs [11]. In particular,
arachidonoyl chains are particularly enriched in phosphatidylinositols
(PI) and in phosphatidylethanolamines (PE) [11,12]. In comparison,
docosahexanoyl moieties are enriched in phosphatidylserines (PS) as
well as PE [11]. The fraction of acyl chains that are docosahexanoic is
greater in brain and heart, compared with other tissue, while the
arachidonoyl moiety is predominant in the PI of most tissues [11].
1.4. Proteins that interact selectively with PUFA
The principal reason for the concentration of particular PUFA in
certain lipid classes is the speciﬁcity of the interaction of certain
enzymeswithmembrane lipids based on their acyl chain composition.
There is a whole range of degrees of speciﬁcity in the interaction
between proteins and lipids with different acyl chains, from cases in
which the protein will interact with only a single molecular species, to
cases inwhich there is a varying degree of preference of one acyl chain
over another. In this review we will refer to proteins that do not
distinguish between one acyl chain and another as “non-speciﬁc” and
those that show varying degrees of preference for one acyl chain over
another as “speciﬁc”. The degree of speciﬁcity varies both among
different proteins as well as being dependent on how different the
acyl chain structures are that are being compared. Phospholipids that
are rich in PUFA have a tendency to be segregated in membranes
based on their exclusion from cholesterol-rich regions [13]. However,
in addition, there are mechanisms to determine which lipid class
these acyl chains are incorporated into. It is this latter aspect, based on
the acyl chain speciﬁcity of protein–lipid interactions, that this review
is based on.
2. Lipoxygenases: example of a well studied protein family with a
binding site for PUFA
Our review focuses mainly on the interaction of proteins with
phospholipid components of membranes that are directly responsible
for the unequal distribution of PUFA among different lipid classes.
Nevertheless, there are also examples of speciﬁc interaction of some
proteins including certain isoforms of fatty acid binding proteins [14]
and of lipoxygenases with PUFA as free fatty acids.
We will discuss lipoxygenases in more detail because these
enzymes have been extensively studied for a number of years and
the crystal structure of several lipoxygenases have been determined
[15]. Lipoxygenases are non-heme iron-containing dioxygenases that
catalyze the stereo-speciﬁc peroxidation of PUFA. The conventional
nomenclature classiﬁes animal lipoxygenases with respect to their
positional speciﬁcity of arachidonic acid oxygenation as 5-LOXs, 8-
LOXs, 11-LOXs, 12-LOXs or 15-LOXs. Proteins with sequence homol-
ogy to mammalian lipoxygenase are found in all animal and plant
species as well as most prokaryotes, but not in archea [15]. However,
the function of lipoxygenase in prokaryotes is not well established. In
addition, PUFA other than arachidonic acid, are found to be the best
substrates for many non-mammalian forms of lipoxygenase. This
presents a complication when applying the same nomenclature to
non-mammalian lipoxygenase as that given above.
Most lipoxygenase enzymes have a single polypeptide chain that
folds into two distinct domains, a small N-terminalβ-barrel domain anda larger domain that is mostly helical and contains the catalytic site of
the enzyme. The N-terminal domain composed of anti-parallel β-
strands has been suggested to be important for membrane binding on
the basis of mutagenesis and limited proteolysis experiments [16,17]. It
remains possible, however, that the N-terminal segment affects the
folding of the catalytic domain. The larger helical catalytic domain
contains the substrate-bindingpocket for bindingPUFAand the catalytic
non-heme iron. The non-heme iron of all lipoxygenase isoforms is
octahedrically coordinated to ﬁve amino acid sidechains and a
hydroxide ligand. The substrate binding pocket is a hydrophobic cavity
that allows transfer of a PUFA from a membrane to this site on the
protein situated near themembrane interface. Hydrophobic amino acid
residues line the binding site but no direct structural information is
available to specify themolecular details of the interaction of PUFAwith
this site. However, there are some suggested differences in the shape of
this hydrophobic binding site among different forms of lipoxygenase
enzymes. In addition, in some lipoxygenase enzymes this site is opened,
while in others it is blocked by other segments of the protein that are
opened by a conformational change [15].
The speciﬁcity of lipoxygenase enzymes for different fatty acids and
for different positions on the fatty acid must be determined by the
location of the susceptible bonds of the substrate in relation to the
components at the enzymeactive site required for catalysis.Mammalian
forms of lipoxygenase preferentially oxidize arachidonic acid, while
these enzymes from plants are generally speciﬁc for linoleic acid. There
are also differences in which of the double bonds are oxidized. This
speciﬁcity exists because of the targeted binding of the fatty acid in the
hydrophobic pocket of the binding site, despite the fact that PUFAs are
extremely ﬂexible molecules. The principal binding forces between
lipoxygenase and these substrates are hydrophobic, π-electron and
ionic interactions. The entry of the substrate into the binding site is
generally considered to proceed with the hydrophobic terminal methyl
end of the fatty acid entering ﬁrst. However, there maybe some cases in
which the substrate enters with the polar carboxyl group ﬁrst that can
then bind to a cationic site on the enzyme. There is some evidence from
X-ray diffraction studies for such an entry [18]. The difference between
“head-ﬁrst” and “tail-ﬁrst” orientation of the substrate may depend on
the nature of the substrate and on the reaction conditions [19–21].
5-Lipoxygenase is the enzyme that catalyzes the formation of both
proinﬂammatory leukotrienes and anti-inﬂammatory lipoxins from
arachidonic acid. Ca2+ is required for the membrane binding and
enzymatic activity of human 5-lipoxygenase [22] and for nuclear
translocation [23]. Ca2+ also enhances themembrane binding of some
other forms of lipoxygenase. Human 5-lipoxygenase is sensitive to
inactivation as a consequence of the oxidation of the catalytic iron by
molecular oxygen [24]. This inactivation process was inhibited by
mutation of the wild type enzyme, allowing for a detailed structural
analysis of the enzyme by crystallography [25]. The crystal structure
was solved to a 2.4 Å resolution that showed that although the active
site residues were highly conserved with those of other lipoxygenase
enzymes, there were distinct differences in the structure, suggesting
that development of speciﬁc inhibitors for 5-lipoxygenase should be
possible [25].
3. Enrichment of phosphatidylinositol-cycle intermediates with
arachidonoyl chains: role of speciﬁc protein interactions
Phosphatidylinositol is the only lipid class that has a speciﬁc
arachidonoyl-containing molecular species in every organ of the rat in
which it has been investigated [11]. The predominantmolecular species
is 1-stearoyl-2-arachidonoyl phosphatidylinositol. Phosphatidylinositol
is a component of the “PI-cycle” in which PI is continually synthesized
and broken down. The PI-cycle is shown in Fig. 1. However, besides
phosphatidylinositol, other lipid intermediates of the PI-cycle, diacyl-
glycerol and phosphatidic acid are not enriched in particular acyl chains.
This can be explained because there is only one predominant source of
Fig. 1. Scheme for the phosphatidylinositol cycle. Enzymes catalyzing each of the
individual steps are shown with their abbreviated names in a blue oval. Intermediates
in the cycle are shown in red. PI4K, phosphatidylinositol-4-kinase; PI4P, phosphatidy-
linositol-4-phosphate; PLC, phospholipase C; DAG, diacyl glycerol; PA, phosphatidic
acid; CDP-DAG, cytidine diphosphate diglyceride; other abbreviations are deﬁned in
the footnote for abbreviations.
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inositol, while there are several metabolic pathways that give rise to
diacylglycerol and phosphatidic acid [26]. Therefore if the PI-cycle is
active, there must be a mechanism to select only the 1-stearoyl-2-
arachidonoyl forms of diacylglycerol or of phosphatidic acid to
participate in this cycle to produce principally one molecular species
of phosphatidylinositol. Such selectivity of molecular species could be
the consequence of spatial segregation of different lipids or as a result of
enzyme speciﬁcity. I would like to discuss the existing evidence that
certain enzymes of the PI-cycle preferentially convert lipid species
having particular acyl chain compositions.
The PI-cycle can be stimulated by hormone activation of a PIP2-
speciﬁc phospholipase C by a variety of mechanisms including
through both G-protein coupled receptors as well as receptor tyrosine
kinases. The mechanism of this activation includes binding to G-
protein subunits, by small GTPases from the Rho and Ras families,
phosphorylation by both receptor and non-receptor tyrosine kinases
as well as by membrane lipid components [27]. PIP2-speciﬁc isoforms
of phospholipase C will catalyze the formation of a diacylglycerol that
is enriched in 1-stearoyl-2-arachidonoyl acyl chains [28]. The next
step in the PI-cycle is the conversion of diacylglycerol to phosphatidic
acid catalyzed by diacylglycerol kinase (DGK) [29]. Among the ten
knownmammalian isoforms of DGK, only one isoform, DGKε, exhibits
speciﬁcity for substrates with particular acyl chains. The speciﬁcity of
DGKε for arachidonoyl-containing diacylglycerol is well established
[30–32]. In addition, DGKε preferentially phosphorylates diacylgly-
cerol having a stearoyl group on the sn-1 position [33]. Thus, DGKε is
selective for the molecular species of diacylglycerol that is produced
in the PI-cycle, i.e. 1-stearoyl-2-arachidonoyl glycerol. In addition,
there is evidence from lipidomic studies that DGKε is closely linked
with PI-cycling, since in whole cells the absence of this enzyme lowers
the arachidonoyl content of PI [12], even though PI is neither the
substrate nor the product of the reaction catalyzed by DGKε.
The phosphatidic acid product of the DGKε-catalyzed reaction is
then converted to CDP-diacylglycerol catalyzed by the enzyme
phosphatidate cytidylyltransferase. There is some evidence that this
enzyme exhibits speciﬁcity for 1-stearoyl-2-arachidonoyl phospha-
tidic acid [34]. Phosphatidylinositol is then formed from this CDP-
diacylglycerol by reaction with inositol, followed by phosphorylation
catalyzed by phosphatidylinositol-4-kinase. Both the alpha (accession
number P42356) and the beta (accession number, Q9UBF8) isoformsof the human phosphatidylinositol-4-kinase have lipoxygenase-like
motifs (see below), but the acyl chain selectivity of this enzyme has
not been studied to our knowledge. The PI-cycle is completed in the
ﬁnal, rate determining step in themajor route for the synthesis of PIP2,
the phosphorylation of phosphatidylinositol-4-phosphate catalyzed
by phosphatidylinositol-4-phosphate-5-kinase. This enzyme has also
been shown to have dependence on the acyl chain composition of the
substrate with high activity observed with 1-stearoyl-2-arachidonoyl
phosphatidylinositol-4-phosphate [35].
Thus, virtually every step in the PI-cycle results in some
enrichment of the lipid intermediates with 1-stearoyl-2-arachidonoyl
acyl chains. The fact that thesemetabolic interconversions correspond
to a cycle means that each of the intermediates will be regenerated
with each turn of the cycle. Consequently any partial enrichment of
the lipid intermediates that occurs in one cycle will be ampliﬁed as a
consequence of the cycle being repeated multiple times.
Another particular aspect of this system is that it exhibits
speciﬁcity for both the sn-1 and sn-2 acyl chains of the lipids. This is
shown by the high content of the1-stearoyl-2-arachidonoyl molecular
species in the phosphatidylinositols and by the ﬁnding that DGKε is
speciﬁc for both acyl chains of diacylglycerol. In the Introduction we
commented that the interaction of proteins with membranes was
more commonly speciﬁc for the headgroups. Not only does this
example show speciﬁcity for the acyl chains, but it shows that they are
so to the extent that interactions of this protein with lipids are
selective for a single molecular species. This speciﬁcity results in an
enrichment of a diacylglycerol with particular acyl chains and
consequently other lipids of the PI-cycle have these same acyl chains.
This is a consequence of the substrate speciﬁcity of DGKε as well as
other enzymes of the PI-cycle.
4. Phosphatidylethanolamine: the lipid class with the highest
enrichment of PUFA: pathways of PE synthesis
Although phosphatidylinositols are highly enriched with 1-
stearoyl-2-arachidonoyl acyl chains, the lipid class most enriched
with arachidonoyl chains is not phosphatidylinositols, but PE. What
then is the mechanism of enrichment of PE with particular acyl
chains?
There are some additional considerations with PE. While the only
PUFA enriched in phosphatidylinositols is arachidonic acid, in the case
of PE there is enrichment with both arachidonoyl and with
docosahexanoyl groups, depending on the organ. Brain and heart
muscle PE are particularly enriched with the docosahexanoyl group
[11]. In addition, PE lipids are composed of substantial amounts of 1-
alkyl-2-acyl forms as well as 1-alkenyl-2-acyl species in addition to
the diacyl component. Finally in mammals there are two routes of
synthesis of PEs one being through decarboxylation of phosphatidyl-
serine and the other through the Kennedy pathway of the reaction of
CDP-ethanolamine with diacylglycerol.
There have been some studies regarding the recognition of acyl
chains by the enzymes involved in PE synthesis. The most speciﬁc
example is with the activity of ethanolamine phosphotransferase that
catalyzes the synthesis of PE from CDP-ethanolamine and diradyl-
glycerols. That study, using an isolated microsomal preparation,
showed that diradyl-glycerols having ether linkages at the sn-1
position of glycerol were much better substrates for this enzyme than
diacylglycerols [36]. For the 1-alkyl-2-acyl glycerols or the 1-alkenyl-
2-acyl glycerols, the nature of the acyl chain at the sn-2 position
appeared to be of minor importance. However, for the diacylglycerols,
although poorer substrates, the 1-palmitoyl-2-arachidonoyl glycerol
was shown to a much better substrate than 1-palmitoyl-2-oleoyl
glycerol [36]. Clearly additional studies are required to ascertain the
nature of the acyl chain selectivity of this enzyme. There is also the
pathway of PE synthesis by decarboxylation of PS. There is some
speciﬁcity for the acyl chains of PS in mitochondrial samples
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iﬁcity varies among different tissues [37]. In brain there is speciﬁcity
for 22:6 acyl chains [37]. Some of the enrichment of PEwith PUFAmay
come as a result of PS enrichment with PUFA, followed by less speciﬁc
decarboxylation. There is a strong preference of phosphatidylserine
synthase-1 (PSS1), the enzyme that catalyzes base exchange of
choline for serine, for forms of PC with 22:6 acyl chains [38]. Thus, the
PS substrate for the formation of PE by decarboxylationwill already be
enriched with PUFA. Combined with the known enrichment of PE in
all tissues with PUFA [11], this suggests that there is speciﬁcity
exhibited by the proteins involved in PE metabolism, to selectively
bind to membranes containing PUFA.5. Development of an understanding of the features common to
many proteins that bind to PUFA
Although there is detailed structural information only for the
lipoxygenases, some common elements among the group of proteins
that bind speciﬁcally to PUFA are beginning to emerge. One of these
elements is the location of the binding site for PUFA. Although the
substrates of these enzymes are hydrophobic and they will incorpo-
rate into membranes, their binding site on the protein is near the
membrane interface. In the case of lipoxygenase, for example,
removal of the most hydrophobic membrane-inserting loops, the β-
barrel structure at the amino terminus, did not destroy the binding
site for arachidonic acid [25,39]. The binding site for arachidonic acid
is a channel formedwithin theα-helical segments in the remainder of
the molecule. This can be appreciated from the structure of the
enzyme derived from X-ray crystallography (Fig. 2). The arachidonic
acid binding site of lipoxygenase is not inserted into the membrane
where it can ﬁnd the hydrophobic substrate; when bound to the
enzyme, the arachidonic acid is completely surrounded by protein and
has no contact with the membrane [40]. Thus, the process of
arachidonic acid binding to lipoxygenase is better described as an
extraction of the substrate from a membrane.Fig. 2. Themolecular structure of human 5-lipoxygenase constructed on the basis of the
crystallographic structure deposited in the protein data bank (3O8Y). Structure of a
single monomer. Note that the membrane-inserting segment is the β-barrel structure
in the upper left-hand portion of the Figure. Arachidonic acid binds to a U-shaped
tunnel within the core of the protein where the catalytic iron is the round, purple ball in
the center of the structure. The protein segment corresponding to the arachidonoyl-
recognizing motif is shown in yellow. α-helical segments, blue; β-structure, red;
connecting segments, green.We have also investigated the properties of the enzyme DGKε and
the extent of insertion of the protein into a membrane. There is no
atomic resolution structure available for this protein, hence some of the
evidence is less direct, but it ﬁts a model that is analogous in many
respects to that of lipoxygenase. DGKε has only one segment that is
sufﬁciently hydrophobic to be predicted to be a transmembrane helix,
i.e. the segment comprising approximately residues 20–40. However,
this segment of the protein can be removed without loss of enzymatic
activity or speciﬁcity [41]. In fact there is evidence that the hydrophobic
segment, with a FLAG-tag attached at the amino terminus, forms a re-
entrant helix that enters and leaves the membrane at the same side,
making it a monotopic protein [42]. In silico modeling studies indicate
that this segment can easily interconvert between a transmembrane
and re-entrant helix. Recent in vitro synthesis experiments suggest that
the N-terminal FLAG tag contributes to the formation of a re-entrant
helix [43]. Hence, the region of DGKε that penetrates the most into the
membrane has no role in binding the arachidonoyl chain of diacylgly-
cerol [41]. By contrast, however, we have identiﬁed a region in the
accessory domain of DGKε [35] that has a similar pattern of amino acid
residues ashas been identiﬁed for lipoxygenases [40].Mutationof anyof
the residues of DGKε that are equivalent to those found to be essential
for arachidonoyl-binding by lipoxygenases results in amarked decrease
in activity [35]. Furthermore, for two of themutants that retainedmore
activity, we demonstrated that their selectivity for arachidonoyl-
containing diacylglycerol was diminished [35]. The lipoxygenase-like
domain in DGKε spans residues 431–443 and is overlapping with a
somewhat hydrophobic segment of residues 436–456. This hydropho-
bic segment appears as a peak in hydrophobicity plots but it is not
predicted to be a transmembrane helix. However, its location in the
sequence next to the lipoxygenase-like domain indicates the arachido-
noyl binding site is close to the membrane interface.
In the case of DGKε, the substrate is diacylglycerol which is much
more hydrophobic than the substrate for lipoxygenases, arachidonic
acid. Therefore, we would not expect the diacylglycerol to be pulled out
of themembrane into aproteinbinding site ashappenswith arachidonic
acid with lipoxygenases. We rather suggest that in the case of 1-
stearoyl-2-arachidonoyl glycerol, only the sn-2 chain of the diacylgly-
cerol is removed from the membrane and not the entire lipid molecule.
The arachidonoyl chain is less hydrophobic than a saturated acyl chain.
The energetics of pulling this single chain of diacylglycerol out of the
membrane may not be much different from the case of lipoxygenases
binding to free arachidonic acid. The suggestion that the arachidonoyl
group binds speciﬁcally to DGKε is supported by our observations that
there is no other acyl chain besides arachidonoyl that can be present in
the sn-2 position of diacylglycerol and result in a substrate with over
about 30%of theactivity of thebest substrate, 1-stearoyl-2-arachidonoyl
glycerol. In contrast, substituting the preferred stearoyl group on the sn-
1 position with arachidonoyl to make1,2-diarachidonoyl glycerol, gives
a substrate that has activity that is comparable to 1-stearoyl-2-
arachidonoyl glycerol (unpublished results). This and other similar
results, indicate that the speciﬁcity for a particular acyl chain at the sn-1
position is not as great as that for the sn-2 position. Nevertheless, the
acyl chain at the sn-1 position does exhibit some selectivity, with the
stearoyl group being favored over either longer or shorter saturated acyl
chains [33]. This indicates that the role of the sn-1 acyl chain is not
simply to provide hydrophobicity or membrane partitioning, but may
serve to determine the depth of insertion of the entire diacylglycerol
substrate into the membrane, determining the alignment of the
hydroxyl group with the active site of the enzyme.
We suggest that there is a similar amino acid pattern in many
proteins that interact with PUFA. The pattern of residues in the
arachidonoyl-recognizing motif for each of these proteins is similar,
but not identical. These groups of required amino acid residues make
up a binding site that we propose has some similarity to that of
lipoxygenases. However, the binding sites for all these enzymes are
clearly not identical. First of all, the substrates for the large group of
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diacylglycerol for DGKε and free arachidonic acid for lipoxygenases.
As an example, there is a cationic residue in lipoxygenases that could
bind the carboxyl group, but such an interaction would not be
relevant for enzymes acting on diacylglycerols. In addition, the nature
of the chemical reaction and the geometry of the transition state will
be different for different enzymes. Nevertheless, the amino acid
pattern that is part of the arachidonoyl-recognition site is similar for
proteins interacting with different PUFA. For DGKε and for mamma-
lian lipoxygenase the enzymes recognize arachidonic acid. However,
for plant lipoxygenases, the favored substrate is linoleic or linolenic
acid [44]. The speciﬁcity of enzymes for different PUFAs is most
dramatically seen by comparing two lipoxygenase isozymes from
maize (Zea mays). One of these isoforms exhibits high activity withα-
linolenic acid but is essentially inactive with arachidonic acid, while
the other isoform has speciﬁcity for linoleic acid [45]. The PUFA that
will be the best substrate depends on the speciﬁc structure of the
binding site of the enzyme, which is determined bymore than just the
presence or absence of this amino acid pattern. Thus the presence of
this lipoxogenase-like pattern of amino acids does not determine the
nature of the PUFA that will be acted upon, but it does indicate that
the protein will bind better to a lipid substrate containing a
polyunsaturated acyl chain rather than a saturated or monounsatu-
rated one. The amino acid pattern is not a unique one, but can be
deﬁned by the sequence L-X(3–4)-R-X(2)-L-X(4)-G, in which -X(n)-
represents n residues of any amino acids in this domain [35]. The ﬁrst
residue of this sequence is L, while for lipoxygenases it is I. Although
this pattern is found in about 2% of known protein sequences,
includingmany proteins that do not interact with PUFA, it has allowed
us to identify sites in other enzymes that are responsible for
interaction with PUFA. The segment of the protein identiﬁed as
having a lipoxygenase-like motif is found in a region that is highly
conserved in evolution as shown by several sequence alignments that
have been recently presented [35].
One of these proteins is phosphatidylinositol-4-phosphate-5-kinase
(PI4P5K). There are three isoforms of this enzyme aswell as products of
alternative splicing. All forms of this enzyme have a lipoxogenase-like
motif. The human isoform 1α has speciﬁcity for brain PI4P which is
mainly the 1-stearoyl-2-arachidonoyl form compared with a dipalmi-
toyl form of PI4P, that is phosphorylated much more slowly [35]. In
addition,mutation of speciﬁc essential residues of the lipoxogenase-like
motif of this protein results in a marked loss of activity [35].
6. Conclusions
Recognition of speciﬁc free fatty acids or acyl chains of lipid
structures must be a common phenomenon in mammalian cells.
Oxidized forms of arachidonic acid are potent signaling lipids and
their formation requires the speciﬁc recognition of arachidonic acid
over other polyunsaturated fatty acids. In addition, the ﬁnding that
PUFA are unequally distributed in different organs and in different
lipid classes is another demonstration of the speciﬁc recognition of
these groups.
The binding of arachidonic acid by lipoxygenases has been well
studied and the crystal structures of many forms of lipoxygenase are
available. It is clear in this case that the protein binds to amembrane and
from that location is able to favorably compete with the membrane
bilayer for binding to arachidonic acid. The arachidonic acid substrate
enters into a channel in the protein that is outside of themembrane but
is lined with hydrophobic residues. For many forms of lipoxygenase
from many different species there is a common pattern of amino acid
residues in the channel that binds arachidonic acid. This amino acid
pattern is I-(X)4-R-(X)2-L-(X)4-G. We have shown that similar features
are found inDGKε, which is the only isoformofmammalianDGKs that is
known to have speciﬁcity for PUFA. For DGKε, the segment that is most
hydrophobic and partitions into the membrane, i.e. residues 20–40, isnot required for substrate bindingor catalytic activity [41]. Therefore the
arachidonoyl moiety of the diacylglycerol substrate must be extracted
from the membrane to bind to DGKε. In addition, among the 10
mammalian isoforms of DGK, DGKε is the one having a pattern of amino
acid residuesmost closely resembling that requiredby lipoxygenases for
binding arachidonic acid. The pattern for DGKε is L-(X)3-R-(X)2-L-(X)4-
G. It differs from the pattern in lipoxygenases by having L as the ﬁrst
residue and by having only 3, rather than 4 residues between the ﬁrst
residue and the required R. Although the two motifs are not identical,
the nature of the substrates and the reaction that is catalyzed by the
DGKε and the lipoxygenases are also quite different, so perhaps one
should expect some differences in the nature of the arachidonoyl
binding site. The argument that the identiﬁed motif is required for
arachidonoyl recognition was shown by the fact that it is highly
conserved among DGKε of different species and mutation of essential
residues in this segment leads to loss of activity and in some cases loss of
selectivity for the arachidonoyl group. The argument is also supported
by the fact that a modest increase in arachidonoyl speciﬁcity can be
introduced into another isoformofDGK,DGKα, by introducing the same
pattern of required amino acid residues as found with DGKε [35].
It remains to be determined how general this motif is for proteins
that recognize PUFA.We have presented evidence that PI4P5K has both
arachidonoyl speciﬁcity as well as a pattern of residues identical to that
of lipoxygenases, except that L, rather than I, is the ﬁrst residue [35].
Certainly not all proteins with this or a similar amino acid pattern will
recognize PUFA as one can ﬁnd examples of non-membrane proteins
with this pattern also, although the pattern is found in only 2% of known
proteins and therefore is not common.However, we have allowed some
small variation in the pattern among the three examples we have
discussed, i.e. lipoxygenases, DGKε and PI4P5K. In addition, it appears
from the example of plant lipoxygenases and others, that other PUFA,
besides arachidonic acid, can have the highest binding afﬁnity to a
protein with a similar amino acid pattern to those discussed above. This
simple predictivemethod is insufﬁcient to determinewhich PUFA binds
most avidly. However, the presence of this motif in a protein known to
have speciﬁcity for PUFAallows for the identiﬁcation of a segment of the
protein important for substrate binding. Because of the importance of
PUFA in biology, further investigation of these relationships is important
to carry out. However, what the ﬁndings already demonstrate is that
there are some common elements among proteins that are unrelated,
except for their property of binding PUFA. These common elements
include a binding site for PUFA that is outside of the membrane,
requiring extraction of the substrate or part of the substrate from the
bilayer to bind to a hydrophibic channel in the protein. This binding site
also has an amino acid pattern equal to or similar to that found in
lipoxygenases that forms part of the substrate binding site.
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